Tianjin Tianyao Pharmaceuticals (600488.SH) subsidiary obtains drug registration certificate for Compound Amino Acid Injection

Tianjin Tianyao Pharmaceuticals (600488.SH) announced that recently, its subsidiary Hubei Tianjin Tianyao Pharmaceuticals Co., Ltd. received the Drug Registration Certificate for Compound Amino Acid Injection (18AA-) approved and issued by the National Medical Products Administration. Compound Amino Acid Injection (18AA-) is used for hypoalbuminemia, low nutritional status, and amino acid supplementation before and after surgery. The drug was registered and filed as a Class 4 chemical drug, and upon approval, it is deemed to have passed the generic drug quality and efficacy consistency evaluation.